| Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours V Martin, C Chiriaco, C Modica, A Acquadro, M Cortese, F Galimi, ... British journal of cancer 120 (5), 527-536, 2019 | 41 | 2019 |
| Targeting phosphatases and kinases: How to checkmate cancer A Turdo, C D’Accardo, A Glaviano, G Porcelli, C Colarossi, L Colarossi, ... Frontiers in cell and developmental biology 9, 690306, 2021 | 37 | 2021 |
| MET/HGF co-targeting in pancreatic cancer: a tool to provide insight into the tumor/stroma crosstalk C Modica, D Tortarolo, PM Comoglio, C Basilico, E Vigna International journal of molecular sciences 19 (12), 3920, 2018 | 31 | 2018 |
| Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody‐“decoy” strategy C Basilico, C Modica, F Maione, E Vigna, PM Comoglio International journal of cancer 143 (7), 1774-1785, 2018 | 17 | 2018 |
| Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody S Cignetto, C Modica, C Chiriaco, L Fontani, P Milla, P Michieli, ... Molecular Oncology 10 (6), 938-948, 2016 | 13 | 2016 |
| HGF/MET Axis induces tumor secretion of tenascin-C and promotes stromal rewiring in pancreatic cancer C Modica, M Olivero, F Zuppini, M Milan, C Basilico, E Vigna Cancers 13 (14), 3519, 2021 | 12 | 2021 |
| Recapitulating thyroid cancer histotypes through engineering embryonic stem cells V Veschi, A Turdo, C Modica, F Verona, S Di Franco, M Gaggianesi, ... Nature Communications 14 (1), 1351, 2023 | 10 | 2023 |
| Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy C Chiriaco, C Donini, M Cortese, S Ughetto, C Modica, I Martinelli, ... Journal of Experimental & Clinical Cancer Research 41 (1), 309, 2022 | 7 | 2022 |
| Targeting of the peritumoral adipose tissue microenvironment as an innovative antitumor therapeutic strategy M Lo Iacono, C Modica, G Porcelli, OR Brancato, G Muratore, P Bianca, ... Biomolecules 12 (5), 702, 2022 | 7 | 2022 |
| A receptor-antibody hybrid hampering MET-driven metastatic spread C Modica, C Basilico, C Chiriaco, N Borrelli, PM Comoglio, E Vigna Journal of Experimental & Clinical Cancer Research 40, 1-12, 2021 | 7 | 2021 |
| Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells R Rotolo, V Leuci, C Donini, F Galvagno, A Massa, MC De Santis, ... Clinical Cancer Research 29 (3), 621-634, 2023 | 6 | 2023 |
| Targeting epigenetic alterations in cancer stem cells P VD, V V Frontiers in Molecular Medicine 2, 1011882, 2022 | 6 | 2022 |
| hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’cancers I Martinelli, C Modica, C Chiriaco, C Basilico, JM Hughes, S Corso, ... Journal of Experimental & Clinical Cancer Research 41 (1), 112, 2022 | 6 | 2022 |
| Dual inhibition of myc transcription and PI3K activity effectively targets colorectal cancer stem cells M Gaggianesi, LR Mangiapane, C Modica, VD Pantina, G Porcelli, ... Cancers 14 (3), 673, 2022 | 4 | 2022 |
| Destroying the shield of cancer stem cells: Natural compounds as promising players in cancer therapy M Lo Iacono, M Gaggianesi, P Bianca, OR Brancato, G Muratore, ... Journal of Clinical Medicine 11 (23), 6996, 2022 | 3 | 2022 |
| Molecular engineering strategies tailoring the apoptotic response to a MET therapeutic antibody C Modica, S Gallo, C Chiriaco, M Spilinga, PM Comoglio, T Crepaldi, ... Cancers 12 (3), 741, 2020 | 3 | 2020 |
| Cancer cell targeting by CAR-T cells: A matter of stemness C D’Accardo, G Porcelli, LR Mangiapane, C Modica, VD Pantina, ... Frontiers in Molecular Medicine 2, 1055028, 2022 | 2 | 2022 |
| Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination C Modica, M Cortese, F Bersani, AM Lombardi, F Napoli, L Righi, R Taulli, ... Cancers 15 (10), 2742, 2023 | 1 | 2023 |
| EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas A Turdo, M Gaggianesi, C D’Accardo, G Porcelli, SD Bella, D Cricchio, ... Frontiers in Immunology 14, 1266265, 2023 | | 2023 |
| Correction: hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of'MET-addicted'cancers M Ilaria, C Modica, C Cristina, B Cristina, H James, C Simona, G Silvia, ... JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 41, 2022 | | 2022 |
